Chemoresistance, radioresistance, and androgen deprivation therapy resistance in prostate cancer

Keyphrases

• Radioresistance 100%
• Androgen Deprivation Therapy Resistance 100%
• Metastatic Castration-resistant Prostate Cancer (mCRPC) 50%
• Migratory Phenotype 25%
• Adherent Junction 25%
• Androgen Signaling 25%
• Dedifferentiation 25%
• Invasive Phenotype 25%
• Androgen Deprivation Therapy 25%
• Invasive Ability 25%
• Cancer Evolution 25%

Biochemistry, Genetics and Molecular Biology

• Cancer Growth Factor 50%
• Anoikis 50%
• Diazepam 25%
• Cadherin 25%
• Cell Dedifferentiation 25%
• Growth Factor Signaling 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Cancer Growth Factor 66%
• Castration Resistant Prostate Cancer 66%